Lingli Dong
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Xeligekimab in the Treatment of Non-Radiographic Axial Spondyloarthritis (NCT07339566) | Lingli Dong | 2026-01-31 |
| Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells (NCT06277427) | Lingli Dong | 2024-02-05 |
Track Lingli Dong automatically
Every clearance here is in the API, with alerts when new ones post.